Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G/A for Royalty Pharma plc Class A Ordinary Shares (RPRX).
- Disclosed ownership: 9.2%.
- Date of event: 30 Jun 2025.
MORGAN STANLEY - 30 Jun 2025 SCHEDULE 13G/A Report for Royalty Pharma plc Class A Ordinary Shares (RPRX)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Symbol
- RPRX
- Shares outstanding
- 422,902,293 shares
- Disclosed Ownership
- 38,907,011 shares
- Ownership
- 9.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Aug 2025, 11:56:29 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 9.2% ownership in Royalty Pharma plc Class A Ordinary Shares (RPRX) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Aug 2025, 11:56.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 9.2% | 38,907,011 | 0 | 34,289,848 | Christopher O'Hara | Authorized Signatory, Morgan Stanley | |
| Morgan Stanley Investment Management Inc. | 8.5% | 35,864,664 | 0 | 31,782,696 | Deidre A. Downes | Authorized Signatory, Morgan Stanley Investment Management Inc. |